Objective: The study aimed to assess the long-term persistent symptoms of patients with diabetes mellitus (DM) and COVID-19 infection at 9 months after acute infection.
Methods: This single-center cross-sectional study was conducted from May 20 to June 1, 2021.
Results: A total of 112 patients were included in the present study.
The predictive role of blood indices in coronavirus disease 2019 (COVID-19) related in-hospital adverse outcomes and post-recovery status is not fully defined. The main aim was to assess the association of complete blood indices measured at baseline with COVID-19 related in-hospital clinical outcomes, including length of hospital and intensive care unit (ICU) stay, receiving mechanical ventilation, degree of lung injury and in-hospital death, and post-recovery status. This retrospective study included patients with newly diagnosed COVID-19 infection from August 20, to September 25, 2020.
View Article and Find Full Text PDFBackground: ECG abnormalities associated with COVID-19 pneumonia and adverse outcome are undefined and poorly described in prior studies.
Objectives: To assess the predictive role of baseline ECG markers of increased risk of malignant arrhythmias and cardiac death for adverse in-hospital outcomes.
Patients And Methods: A retrospective study included 93 patients of newly diagnosed COVID-19 with features consistent with pneumonia who were admitted to the hospital from August 20 to September 20, 2020.
Ann Noninvasive Electrocardiol
May 2021
Background: Little is known about the role of ECG markers of increased risk of sudden cardiac death during the acute period of coronavirus disease 2019 ( COVID-19) pneumonia.
Objectives: To evaluate ECG markers of sudden cardiac death on admission, including the index of cardiac electrophysiological balance (iCEB) (QTc/QRS) and transmural dispersion of repolarization (TDR) (T from peak to end (Tp-e) interval and Tp-e/QTc), in patients with COVID-19 pneumonia.
Patients And Methods: This cross-sectional study included 63 patients with newly diagnosed COVID-19 pneumonia who presented to the outpatient clinic or admitted to the respiratory care unit between August 20 and September 15, 2020.
Background And Aims: There is limited data about the prognosis and impact of COVID-19 pneumonia on patients with diabetes mellitus (DM). We aimed to assess blood indices, ECG markers of sudden death and malignant arrhythmias on admission, and diabetes lowering drugs as possible predictors of adverse in-hospital outcome and COVID-19 pneumonia recovery status.
Methods: A retrospective study included patients with newly diagnosed COVID-19 pneumonia from August 20, to October 5, 2020.